Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg and increased by 2.5 mg every 4 weeks up to a maintenance dose of 5-15 mg based on tolerability and therapeutic response
HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality
ACOD1-mediated lysosomal membrane permeabilization contributes to Mycobacterium tuberculosis-induced macrophage death
Nemkov, T
We have previously demonstrated that enhanced oxidative phosphorylation and reduced dependence on glycolysis is associated with a radioresistant phenotype in oesophageal adenocarcinoma (21, 22) and rectal adenocarcinoma (23), respectively, suggesting that targeting energy metabolism, specifically oxidative phosphorylation, may be an effective strategy to enhance therapeutic response to neoCRT (42)
KLOwens custom metal self-ligating (SL) bracket has earned Honorable Mention 2 years in a row at the AAOs Ortho Innovator Awardsrecognition that highlights its impact in private practice